Primary Large B-Cell Lymphomas of Immune-Privileged Sites With IRF4 Rearrangement: Clinicopathological and Molecular Characterization. // Modern Pathology. – URL: https://www.sciencedirect.com/science/article/pii/S0893395226001274?dgcid=rss_sd_all
Primary Large B-Cell Lymphomas of Immune-Privileged Sites With IRF4 Rearrangement: Clinicopathological and Molecular Characterization. Modern Pathology. https://www.sciencedirect.com/science/article/pii/S0893395226001274?dgcid=rss_sd_all
“Primary Large B-Cell Lymphomas of Immune-Privileged Sites With IRF4 Rearrangement: Clinicopathological and Molecular Characterization.” Modern Pathology.
@article{article59153,
title = {Primary Large B-Cell Lymphomas of Immune-Privileged Sites With IRF4 Rearrangement: Clinicopathological and Molecular Characterization},
journal = {Modern Pathology},
url = {https://www.sciencedirect.com/science/article/pii/S0893395226001274?dgcid=rss_sd_all}
}
ABSTRACT High‐dimensional flow cytometry measures immune cells at single‐cell resolution, enabling systematic characterization of cell populations at scale. But harnessing this potential requires seamless interoperability between the...
Abstract The intraneuronal accumulation of amyloid‐β (Aβ) is an early pathogenic event in Alzheimer's disease (AD), initiating a pathological cascade that includes synaptic dysfunction, metabolic deficits, and eventual neuronal loss....